These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice. Mazumdar T; Anam K; Ali N Vaccine; 2004 Mar; 22(9-10):1162-71. PubMed ID: 15003644 [TBL] [Abstract][Full Text] [Related]
10. Diminished CD4+/CD25+ T cell and increased IFN-gamma levels occur in dogs vaccinated with Leishmune in an endemic area for visceral leishmaniasis. de Lima VM; Ikeda FA; Rossi CN; Feitosa MM; Vasconcelos RO; Nunes CM; Goto H Vet Immunol Immunopathol; 2010 Jun; 135(3-4):296-302. PubMed ID: 20132994 [TBL] [Abstract][Full Text] [Related]
12. Peripheral blood mononuclear cell supernatants from asymptomatic dogs immunized and experimentally challenged with Leishmania chagasi can stimulate canine macrophages to reduce infection in vitro. Rodrigues CA; Batista LF; Teixeira MC; Pereira AM; Santos PO; de Sá Oliveira GG; de Freitas LA; Veras PS Vet Parasitol; 2007 Feb; 143(3-4):197-205. PubMed ID: 17045743 [TBL] [Abstract][Full Text] [Related]
13. [Canine leishmaniasis. New concepts of epidemiology and immunopathology: their impact in the control of human visceral leishmaniasis]. Abranches P; Campino L; Santos-Gomes GM Acta Med Port; 1998 Oct; 11(10):871-5. PubMed ID: 10021781 [TBL] [Abstract][Full Text] [Related]
14. Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis. Fujiwara RT; Vale AM; França da Silva JC; da Costa RT; Quetz Jda S; Martins Filho OA; Reis AB; Corrêa Oliveira R; Machado-Coelho GL; Bueno LL; Bethony JM; Frank G; Nascimento E; Genaro O; Mayrink W; Reed S; Campos-Neto A Vet Res; 2005; 36(5-6):827-38. PubMed ID: 16120256 [TBL] [Abstract][Full Text] [Related]
16. Antibiotic resistance free plasmid DNA expressing LACK protein leads towards a protective Th1 response against Leishmania infantum infection. Ramos I; Alonso A; Peris A; Marcen JM; Abengozar MA; Alcolea PJ; Castillo JA; Larraga V Vaccine; 2009 Nov; 27(48):6695-703. PubMed ID: 19747996 [TBL] [Abstract][Full Text] [Related]
17. IL-6 and TNF-alpha production during active canine visceral leishmaniasis. de Lima VM; Peiro JR; de Oliveira Vasconcelos R Vet Immunol Immunopathol; 2007 Jan; 115(1-2):189-93. PubMed ID: 17097150 [TBL] [Abstract][Full Text] [Related]
18. Organ-specific immunity in canine visceral leishmaniasis: analysis of symptomatic and asymptomatic dogs naturally infected with Leishmania chagasi. Sanchez MA; Diaz NL; Zerpa O; Negron E; Convit J; Tapia FJ Am J Trop Med Hyg; 2004 Jun; 70(6):618-24. PubMed ID: 15211002 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of the P-8 amastigote antigen in the experimental model of canine visceral leishmaniasis. Carrillo E; Ahmed S; Goldsmith-Pestana K; Nieto J; Osorio Y; Travi B; Moreno J; McMahon-Pratt D Vaccine; 2007 Feb; 25(8):1534-43. PubMed ID: 17178178 [TBL] [Abstract][Full Text] [Related]
20. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10. Bhaumik SK; Naskar K; De T Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]